CME Symposium on Non-Statin Therapy for LDL-Cholesterol Reduction in Primary and Secondary PreventionThis CME Symposium takes place on Friday, February 23, 2018 from 6:45 PM - 9:00 PM at the Hyatt Hill Country, Fredericksburg Ballroom A-D in San Antonio, Texas.
By: CMEPlanet James Underburg, MD, MS (Chair) Clinical Assistant Professor of Medicine New York University School of Medicine New York, New York Alan Brown, MD Clinical Associate Professor Loyola University Medical Center - Stritch School of Medcine Chicago, Illinois Peter Jones, MD Associate Professor of Medicine Baylor College of Medicine Houston, Texas Pamela Morris, MD Associate Professor of Medicine Medical University of South Carolina Charleston, South Carolina Click to Register Online This program will focus on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention. An interpretation of recently presented and published secondary analyses from cardiovascular outcome trials with non-statin agents will provide lipid specialists with a more comprehensive evaluation of the efficacy and safety of non-statin therapy in patients with atherosclerotic cardiovascular disease (ASCVD). Attendees will also receive an expert assessment of non-statin therapy for primary prevention. Four interactive challenging cases for lipid specialists with "real-world" In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Voxmedia LLC. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity is supported by an educational donation provided by Amgen. Pre-registration is for planning purposes only. For additional CME activities and online CME courses, visit CMEPlanet. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|